$28.35
0.69% today
Nasdaq, Feb 05, 04:18 pm CET
ISIN
US14843C1053
Symbol
CSTL

Castle Biosciences Inc Stock price

$28.15
-1.21 4.12% 1M
+6.30 28.83% 6M
+1.50 5.63% YTD
+4.85 20.82% 1Y
-14.78 34.43% 3Y
-2.65 8.60% 5Y
+6.75 31.54% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
-0.60 2.09%
ISIN
US14843C1053
Symbol
CSTL
Sector

Key metrics

Market capitalization $788.41m
Enterprise Value $535.36m
P/E (TTM) P/E ratio 140.82
EV/FCF (TTM) EV/FCF 13.37
EV/Sales (TTM) EV/Sales 1.72
P/S ratio (TTM) P/S ratio 2.53
P/B ratio (TTM) P/B ratio 1.79
Revenue growth (TTM) Revenue growth 62.43%
Revenue (TTM) Revenue $311.88m
EBIT (operating result TTM) EBIT $-1.04m
Free Cash Flow (TTM) Free Cash Flow $40.03m
Cash position $279.79m
EPS (TTM) EPS $0.20
P/E forward 69.14
P/S forward 2.41
EV/Sales forward 1.63
Short interest 6.15%
Show more

Is Castle Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Castle Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Castle Biosciences Inc forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a Castle Biosciences Inc forecast:

Buy
100%

Financial data from Castle Biosciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
312 312
62% 62%
100%
- Direct Costs 67 67
28% 28%
22%
245 245
75% 75%
78%
- Selling and Administrative Expenses 180 180
11% 11%
58%
- Research and Development Expense 53 53
2% 2%
17%
12 12
117% 117%
4%
- Depreciation and Amortization 13 13
13% 13%
4%
EBIT (Operating Income) EBIT -1.04 -1.04
99% 99%
0%
Net Profit 6.08 6.08
108% 108%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Castle Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Castle Biosciences Inc Stock News

Neutral
Business Wire
19 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle will share data supporting its dermatologic portfolio of tests for skin cancer through poster presentations at the Maui Derm Hawaii meeting.
Neutral
Business Wire
24 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced certain unaudited preliminary performance results for the fourth quarter and year ended Dec. 31, 2024. “Our strong fourth quarter performance underscores continued momentum built throughout 2024, reflecting the strength of our...
Neutral
Business Wire
about one month ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #Barrettsesophagus--Castle Biosciences has received assay approval from the New York State Department of Health (NYSDOH) for its TissueCypher Barrett's Esophagus test.
More Castle Biosciences Inc News

Company Profile

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.

Head office United States
CEO Derek Maetzold
Employees 610
Founded 2007
Website www.castlebiosciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today